Company / Gross Margin
Regenerative Medical Technology Group Inc. Gross Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
55.1%
FY2025
5-year range
34.3% / 69.5%
FY2021-FY2025
Trend
-19.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from 69.5% to 55.1% over the past 2 years.
Based on SEC 10-K filings.
55.1% in FY2025 with a 5-year CAGR of +34.9%.
Declined from 69.5% to 55.1% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -2.2pp
- 5-Year Change
- +34.9pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, gross margin decreased 19.8% year-over-year.
- Peak gross margin was recorded in FY2023.
- Lowest gross margin in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -19.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 55.1% | -19.8% |
| FY2024 | 68.7% | -1.2% |
| FY2023 | 69.5% | +21.3% |
| FY2022 | 57.3% | +67.1% |
| FY2021 | 34.3% | +69.8% |
| FY2020 | 20.2% | +123.9% |
| FY2019 | -84.5% | -132.3% |
| FY2018 | -36.4% | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026